Let's talk medical research

Patrick Gee didn't know that there were any problems with his kidneys until a doctor diagnosed him with kidney failure. Years on dialysis, four surgeries, 47 days in the hospital, and one successful kidney transplant later, he's participated in two clinical trials and become a proud advocate for the American Kidney Fund.

Joining a clinical trial is a significant decision, and there are several personal factors to keep in mind when deciding whether to join – not to mention including the opinions of family members and your doctor.

In early March, Antidote's Head of Partnerships Lindsey Wahlstrom-Edwards and I attended the 2019 Bridging Clinical Research & Clinical Health Care Collaborative to share findings from our joint research on The Patient Perspective on Clinical Trials.

When it comes time to begin recruiting for a clinical trial, there are many different approaches you can take to try to reach patients who will be the right fit for your study. Just as important as knowing what strategies may work for your recruitment project is understanding what to avoid. Here are seven common pitfalls that won’t work for clinical trial patient recruitment.

We know that as clinical trial protocols are getting more complex, it’s getting more and more difficult to find the right patient to take part in a particular trial. As a result, most clinical trial sponsors — and their sites and recruitment companies — are turning to online clinical trial patient recruitment. This can look like Facebook ads, or Google paid search, or display ads. It can even ...

With clinical trial protocols becoming ever more complex, it can feel like it’s never been more difficult to find patients who are both eligible for and interested in a particular clinical trial. Traditional methods of recruitment are becoming less impactful, which is why it’s time to consider a new approach: precision recruitment.

Medicine is advancing every day, and treatments are becoming more and more precise. This is, of course, good news for patients in need of new and different treatment options. But as treatments become more targeted, so do clinical trials. It can feel like it’s never been more difficult to recruit patients to take part in clinical trials than it is today.

We’re thrilled to share that our CEO, Laurent Schockmel, has been named a top 40 Healthcare Transformer by Medical Marketing & Media (MM&M). This honor is given to visionaries driving innovation at the intersection of healthcare and technology, and it’s exciting to see Laurent in such great company. Laurent took the helm as CEO of Antidote in 2018 with the objective of harnessing our ...

At Antidote, we talk a lot about how our search tool makes it easier to match with clinical trials you may qualify for. But what happens after you conduct your search?

It's an exciting time to consider participating in Parkinson's research, says Katie Kopil, PhD, Director of Research Partnerships at The Michael J. Fox Foundation for Parkinson's Research (MJFF).